LAZARD ASSET MANAGEMENT LLC - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 226 filers reported holding EDITAS MEDICINE INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$35
+75.0%
4,595
+81.4%
0.00%
Q2 2023$20
+11.1%
2,533
-2.1%
0.00%
Q1 2023$18
-61.7%
2,587
-52.8%
0.00%
Q4 2022$47
-100.0%
5,484
-42.6%
0.00%
Q3 2022$116,000
+13.7%
9,552
+10.1%
0.00%
Q2 2022$102,000
-95.7%
8,679
-93.1%
0.00%
-100.0%
Q1 2022$2,375,000
-1.3%
124,905
+37.8%
0.00%0.0%
Q4 2021$2,406,000
+32.9%
90,656
+105.7%
0.00%
+50.0%
Q3 2021$1,810,000
-23.9%
44,069
+4.9%
0.00%
-33.3%
Q2 2021$2,378,000
+8707.4%
41,995
+6360.8%
0.00%
Q1 2021$27,000
-87.6%
650
-79.0%
0.00%
Q4 2020$217,000
+10750.0%
3,101
+3825.3%
0.00%
Q2 2020$2,000790.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q1 2023
NameSharesValueWeighting ↓
Deep Track Capital, LP 7,101,935$55,395,0932.14%
Green Alpha Advisors, LLC 77,188$602,0660.46%
Woodline Partners LP 3,259,710$25,425,7380.30%
TANG CAPITAL MANAGEMENT LLC 200,000$1,560,0000.22%
Spectrum Planning & Advisory Services Inc. 14,038$109,4960.17%
PDT Partners, LLC 156,515$1,220,8170.15%
CALTON & ASSOCIATES, INC. 13,420$104,6760.15%
Corton Capital Inc. 29,365$229,0470.12%
CAXTON ASSOCIATES LP 61,223$477,5390.07%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 119,287$930,4390.06%
View complete list of EDITAS MEDICINE INC shareholders